Generation Bio Share Holder Equity 2020-2023 | GBIO
Generation Bio share holder equity from 2020 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
Generation Bio Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$203 |
| 2022 |
$282 |
| 2021 |
$382 |
| 2020 |
$268 |
| 2019 |
$17 |
Generation Bio Quarterly Share Holder Equity
(Millions of US $) |
| 2023-12-31 |
$203 |
| 2023-09-30 |
$232 |
| 2023-06-30 |
$254 |
| 2023-03-31 |
$279 |
| 2022-12-31 |
$282 |
| 2022-09-30 |
$309 |
| 2022-06-30 |
$325 |
| 2022-03-31 |
$353 |
| 2021-12-31 |
$382 |
| 2021-09-30 |
$407 |
| 2021-06-30 |
$433 |
| 2021-03-31 |
$459 |
| 2020-12-31 |
$268 |
| 2020-09-30 |
$287 |
| 2020-06-30 |
$304 |
| 2020-03-31 |
$0 |
| 2019-12-31 |
|
| 2019-09-30 |
$0 |
| 2019-06-30 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.193B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
